SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-028754
Filing Date
2022-08-09
Accepted
2022-08-09 16:10:46
Documents
13
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20220809.htm   iXBRL 8-K 39504
2 EX-99.1 mtcr-ex991_6.htm EX-99.1 156200
  Complete submission text file 0001564590-22-028754.txt   336256

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220809.xsd EX-101.SCH 5593
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220809_lab.xml EX-101.LAB 20063
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220809_pre.xml EX-101.PRE 11937
7 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20220809_htm.xml XML 3674
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 221148382
SIC: 2834 Pharmaceutical Preparations